Literature DB >> 23392822

Generalized subcutaneous phaeohyphomycosis caused by Phialophora verrucosa: report of a case and review of literature.

Zhongsheng Tong1, Sharon C-A Chen, Liuqing Chen, Bilin Dong, Ruoyu Li, Zhimin Hu, Ping Jiang, Dongsheng Li, Yiqun Duan.   

Abstract

We report a case of subcutaneous phaeohyphomycosis due to Phialophora verrucosa in a 64-year-old Chinese farmer suffering from CD4+ lymphopenia. He presented with diffuse and infiltrated plaques involving the entire face including the eyes, neck, occiput, and extending to the dorsal regions of his torso. The patient is notable for the discrete multifocal nature of the illness in the absence of disseminated infection and rarity of P. verrucosa as a cause of subcutaneous phaeohyphomycosis.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23392822     DOI： 10.1007/s11046-013-9626-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN： 0301-486X            Impact factor:   2.574


  21 in total

1.  Subcutaneous phaeohyphomycosis caused by Exophiala jeanselmei in a patient with advanced tuberculosis.

Authors:  H U Kim; S H Kang; T Matsumoto
Journal:  Br J Dermatol       Date:  1998-02       Impact factor: 9.302

2.  Subcutaneous phaeohyphomycosis caused by Lasiodiplodia theobromae and successfully treated surgically.

Authors:  Richard C Summerbell; S Krajden; R Levine; M Fuksa
Journal:  Med Mycol       Date:  2004-12       Impact factor: 4.076

Review 3.  Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents.

Authors:  C J Clancy; J R Wingard; M Hong Nguyen
Journal:  Med Mycol       Date:  2000-04       Impact factor: 4.076

Review 4.  Emergence of black moulds in fungal disease: epidemiology and therapy.

Authors:  F Silveira; M Nucci
Journal:  Curr Opin Infect Dis       Date:  2001-12       Impact factor: 4.915

5.  Voriconazole treatment for less-common, emerging, or refractory fungal infections.

Authors:  John R Perfect; Kieren A Marr; Thomas J Walsh; Richard N Greenberg; Bertrand DuPont; Juliàn de la Torre-Cisneros; Gudrun Just-Nübling; Haran T Schlamm; Irja Lutsar; Ana Espinel-Ingroff; Elizabeth Johnson
Journal:  Clin Infect Dis       Date:  2003-04-22       Impact factor: 9.079

Review 6.  Hyalohyphomycosis and phaeohyphomycosis: two global disease entities of public health importance.

Authors:  L Ajello
Journal:  Eur J Epidemiol       Date:  1986-12       Impact factor: 8.082

7.  Subcutaneous cystic granuloma caused by Phialophora verrucosa.

Authors:  T Iwatsu; M Miyaji
Journal:  Mycopathologia       Date:  1978-11-10       Impact factor: 2.574

8.  Phialophora verrucosa-induced subcutaneous phaeohyphomycosis. Fine needle aspiration findings.

Authors:  V J Schnadig; E G Long; J M Washington; M C McNeely; B A Troum
Journal:  Acta Cytol       Date:  1986 Jul-Aug       Impact factor: 2.319

9.  Exophiala jeanselmei infection in a heart transplant recipient successfully treated with oral terbinafine.

Authors:  William A Agger; David Andes; Joshua W Burgess
Journal:  Clin Infect Dis       Date:  2004-05-11       Impact factor: 9.079

10.  Multifocal subcutaneous phaeohyphomycosis caused by Phialophora verrucosa.

Authors:  Masatomo Kimura; Akio Goto; Tomoko Furuta; Takao Satou; Shigeo Hashimoto; Kazuko Nishimura
Journal:  Arch Pathol Lab Med       Date:  2003-01       Impact factor: 5.534
View more
  6 in total

1.  In vitro activities of nine antifungal drugs and their combinations against Phialophora verrucosa.

Authors:  Yali Li; Zhe Wan; Ruoyu Li
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

2.  1,10-phenanthroline inhibits the metallopeptidase secreted by Phialophora verrucosa and modulates its growth, morphology and differentiation.

Authors:  Marcela Queiroz Granato; Priscila de Araújo Massapust; Sonia Rozental; Celuta Sales Alviano; André Luis Souza dos Santos; Lucimar Ferreira Kneipp
Journal:  Mycopathologia       Date:  2014-12-12       Impact factor: 2.574

3.  Impairment of Immune Response against Dematiaceous Fungi in Card9 Knockout Mice.

Authors:  Weiwei Wu; Ruijun Zhang; Xiaowen Wang; Yinggai Song; Zhengyang Liu; Wenling Han; Ruoyu Li
Journal:  Mycopathologia       Date:  2016-07-15       Impact factor: 2.574

4.  1,10-Phenanthroline-5,6-Dione-Based Compounds Are Effective in Disturbing Crucial Physiological Events of Phialophora verrucosa.

Authors:  Marcela Queiroz Granato; Diego de Souza Gonçalves; Sergio Henrique Seabra; Malachy McCann; Michael Devereux; André Luis Souza Dos Santos; Lucimar Ferreira Kneipp
Journal:  Front Microbiol       Date:  2017-01-30       Impact factor: 5.640

5.  Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors: blockage of its enzymatic activity and interference with fungal growth and macrophage interaction.

Authors:  Marcela Q Granato; Ingrid S Sousa; Thabatta L S A Rosa; Diego S Gonçalves; Sergio H Seabra; Daniela S Alviano; Maria C V Pessolani; André L S Santos; Lucimar F Kneipp
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

6.  Biodiversity and human-pathogenicity of Phialophora verrucosa and relatives in Chaetothyriales.

Authors:  Y Li; J Xiao; G S de Hoog; X Wang; Z Wan; J Yu; W Liu; R Li
Journal:  Persoonia       Date:  2016-08-02       Impact factor: 11.051
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.